Naturally, the gold promoters are out in force. The problem with their theories has always been that they are dead wrong. The REAL BULL MARKET will see the metals rise with equit...
It’s no secret that the Chinese stock market was off to a terrible start this 2016, as the government considered lifting emergency measures only to end up adding more uncertainty...
Inflation could be worse in the euro-zone: headline inflation rose to 0.4% as expected and core CPI beat with 1%. This is a small comfort to the ECB and its efforts in battling def...
US economic output weakened in last year’s fourth quarter, according to this morning’s initial estimate of GDP. The pace decelerated to 0.7%, down from Q3’s 2.0% rise (seas...
And so the final quarter of 2015 is in the history books and we can officially accuse the US Bureau of Economic Analysis of “peddling fiction” about the US recovery, be...
Shares of Gilead (GILD), a leader in the hepatitis C virus treatment space, are sliding this morning after one competitor’s hep C drug was granted FDA approval and another...
Today is the last day of the first month of the year. I favor monthly charts over weekly and weekly charts over daily. Wanted to take a long-term view of the Nasdaq 100 on a monthl...
The US dollar seems to be on the back foot following a cautious FOMC statement and poor data. BNP Paribas says dollar bulls can keep the faith: Here is their view, courtesy of e...
Inovio Pharmaceuticals (INO) shares are rising again this morning as the Zika virus continues to gain attention and its CEO says the company is “ahead of the pack” in d...
With the final trading day of January upon us, it’s time once again, to outline my potential stock buys for the upcoming month. The point of these posts is to help take some of t...